Dara Corrigan
Takoma Park,MD
Summary
Dynamic leader who thrives on immersing in new subjects, collaborating with exceptional teams to achieve groundbreaking goals. Passionate about pushing boundaries and breaking through barriers to accomplish feats once thought impossible. Visionary individual constantly seeking innovative solutions, challenging the status quo to drive unprecedented success. Committed to fostering a culture of excellence and continuous improvement, inspiring others to reach new heights of achievement.
Overview
15
15
years of professional experience
Work History
Deputy Administrator and Director, Center for Program Integrity
Centers for Medicare and Medicaid Services
08.2021 - 05.2025
- In fiscal year 2023, led the Centers for Medicare and Medicaid to save Medicare an estimated $14.9 billion and produce a return on investment of $8.3 to $1.
- Transformed the approach to fraudulent hospices by partnering with stakeholders and Congress to change the way that hospice providers enroll in Medicare, beneficiaries are notified that they are choosing hospice and targeting those hospices that provide little to no care.
Vice President, Government Affairs and Policy
Fresenius Kabi
01.2018 - 01.2021
- Developed public policy strategies around compounding and biosimilars to to influence Congress, the Food and Drug Administration, and the Centers for Medicare and Medicaid Services to ensure approval of biosimilar applications and profitability of sterile injectable drugs portfolio
- Served as an Officer of the Biosimilars Forum, a nonprofit organization dedicated to expanding access and ensuring affordability of biosimilars.
- Cultivated strong relationships with key stakeholders, including customers, vendors, regulators, and community leaders to promote collaboration and long-term success.
Associate Commissioner for Global Regulatory Policy
United States Food and Drug Administration
01.2015 - 01.2018
- Lead FDA negotiator of an historic mutual recognition agreement with 27 countries in the European Union that allows for reliance upon each other’s drug manufacturing inspections.
Director, Europe Office
United States Food and Drug Administration
01.2013 - 01.2015
- As the FDA’s senior representative in Europe, led a multi-disciplinary team in Brussels, London, and the United States to analyze key regulatory issues in Europe to advance the safety and trade interests of the United States.
Associate Commissioner for Regulatory Affairs
United States Food and Drug Administration
01.2010 - 01.2012
- Led 4,000 employees across the United States responsible for import safety, inspections, laboratory testing, and enforcement.
- Oversaw the development of a handheld device that allows FDA investigators to detect counterfeit drugs (65 devices developed that are used domestically and overseas).
Education
Juris Doctor -
University of Virginia
Charlottesville, VA05.1990
Bachelor of Arts -
Baylor University
Waco, TX12.1986
Skills
- Led teams from 3-3,000 people across the United States and in the European Union
- Managed budgets exceeding $1 billion
- Negotiated trade agreement on behalf of the FDA with the European Union
- Policy expert on Medicare, Medicaid, program integrity, private insurance and drug safety
- Unique expertise on program integrity based upon personal experience as a litigator for the Department of Justice, Acting Inspector General, private practice, FDA, CMS and private corporation
Awards
- Leadership Award from the National Health Care Anti-Fraud Association (2025)
- Administrator’s Award for Exceptional Performance (2023)
- Presidential Distinguished Rank Award (2017)
- FDA Commissioner’s Special Citation (2016, 2017)
- International Women of Courage Award – U.S. Department of State (2016)
Boards
- Treasurer, Lumina Theatre – Oversight of financial strategy and compliance for nonprofit arts organization (3 years)
- Board Member, National Health Care Anti-Fraud Association – Advising on best practices for fraud prevention and financial accountability in healthcare (4 years).
- Board Member and Officer, Biosimilars Forum – Steering policy initiatives to expand biosimilar accessibility and affordability (2 years).
Timeline
Deputy Administrator and Director, Center for Program Integrity
Centers for Medicare and Medicaid Services
08.2021 - 05.2025
Vice President, Government Affairs and Policy
Fresenius Kabi
01.2018 - 01.2021
Associate Commissioner for Global Regulatory Policy
United States Food and Drug Administration
01.2015 - 01.2018
Director, Europe Office
United States Food and Drug Administration
01.2013 - 01.2015
Associate Commissioner for Regulatory Affairs
United States Food and Drug Administration
01.2010 - 01.2012
Juris Doctor -
University of Virginia
Bachelor of Arts -
Baylor University
Similar Profiles
Andrew K. KeenanAndrew K. Keenan
Health Insurance Specialist at Department of Health and Human Service / Centers for Medicare and Medicaid Services / Center for Medicare/ Performance-Based Payment Policy Group (P3)Health Insurance Specialist at Department of Health and Human Service / Centers for Medicare and Medicaid Services / Center for Medicare/ Performance-Based Payment Policy Group (P3)
Wen SongWen Song
Data Scientist at Centers for Medicare and Medicaid Services (CMS)Data Scientist at Centers for Medicare and Medicaid Services (CMS)
Gregory BottianiGregory Bottiani
Health Insurance Specialist at Centers for Medicare and Medicaid Services (CMS)Health Insurance Specialist at Centers for Medicare and Medicaid Services (CMS)
Courtney PaughCourtney Paugh
Lead Front Desk/ Billing at Foot and Ankle Specialists of the Mid-AtlanticLead Front Desk/ Billing at Foot and Ankle Specialists of the Mid-Atlantic
Joselyn VargasJoselyn Vargas
Host at Mi RanchitoHost at Mi Ranchito